Lv3
210 积分 2025-11-26 加入
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
2个月前
已完结
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
2个月前
已完结
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
2个月前
已完结
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study
2个月前
已完结
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy
2个月前
已完结
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
2个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
5个月前
已完结
IgA Nephropathy
6个月前
已完结
皖公网安备34019202002308
